聚乙二醇干扰素α—2a联合利巴韦林治疗慢性丙型病毒性肝炎的临床观察(1)
聚乙二醇干扰素α—2a联合利巴韦林治疗慢性丙型病毒性肝炎的临床观察,慢性病型病毒性肝炎,治疗效果
【摘 要】目的:探讨聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型病毒性肝炎的临床效果。方法:选取我院2007年5月~2013年1月收治的100例慢性丙型肝炎患者,抽签随机分为治疗组与对照组各50例,治疗组予以聚乙二醇干扰素α-2a联合利巴韦林治疗,对照组予以干扰素α-2a皮下注射联合利巴韦林治疗,对比2组疗效。结果:两组各阶段ALT复常率、应答率对比无统计学差异(P>0.05)。治疗组不良发应例数均少于对照组(P<0.05)。结论:聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型病毒性肝炎与干扰素α-2a皮下注射联合利巴韦林疗法应答率等方面相似,不良反应发生率略低。【关键词】聚乙二醇干扰素;利巴韦林;慢性病型病毒性肝炎;治疗效果
【中图分类号】R512.63 【文献标识码】a 【文章编号】1004-7484(2014)04-1888-01
Clinical observation of peginterferon α-2a and ribavirin treatment of chronic hepatitis C
Quanshunai
(The people's Hospital of Jilin province Tumen City Department of infectious diseases 133100)
【Abstract】Objective: To investigate peginterferon α-2a and ribavirin treatment of chronic hepatitis C clinical results. Methods: 100 cases of hepatitis in patients with chronic hepatitis C in our hospital during May 2007 - January 2013 were randomly divided into the treatment group and control group(50 cases in each group) ......
您现在查看是摘要页,全文长 3315 字符。